CABOTEGRAVIR

Clinical trials for CABOTEGRAVIR explained in plain language.

Never miss a new study

Get alerted when new CABOTEGRAVIR trials appear

Sign up with your email to follow new studies for CABOTEGRAVIR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New Long-Acting HIV combo shot aims to simplify treatment

Disease control Not yet recruiting

This study looks at how well a long-acting combination of two HIV drugs (cabotegravir and lenacapavir) works in 50 adults with HIV-1. Participants either already take this treatment or will start it by doctor's order. The main goal is to see if the virus stays suppressed (below 5…

Matched conditions: CABOTEGRAVIR

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

CABOTEGRAVIR

Get alerted when new CABOTEGRAVIR trials appear

New Long-Acting HIV combo shot aims to simplify treatment